Bio-Rad Laboratories (BIO-B) Revenue (2009 - 2026)

Bio-Rad Laboratories (BIO-B) has 18 years of Revenue data on file, last reported at $592.1 million in Q1 2026.

• Quarterly Revenue rose 1.14% year-over-year to $592.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 billion (up 1.92% YoY) and the FY2025 annual result came in at $2.6 billion, up 0.65% from the prior year.
• Revenue eased to $592.1 million in Q1 2026 per BIO-B's latest filing, from $693.2 million in the prior quarter.
• Across five years, Revenue topped out at $730.3 million in Q4 2022 and bottomed at $585.4 million in Q1 2025.
• The 5-year median for Revenue is $667.5 million (2024), against an average of $659.7 million.
• The widest annual swing landed in 2024, when Revenue dropped 9.75%; it then gained 3.85% in 2025.
• Tracing BIO-B's Revenue over 5 years: stood at $730.3 million in 2022, then slipped by 6.72% to $681.2 million in 2023, then declined by 2.01% to $667.5 million in 2024, then advanced by 3.85% to $693.2 million in 2025, then dropped by 14.58% to $592.1 million in 2026.
• Per Business Quant, the three latest BIO-B Revenue figures stand at $592.1 million (Q1 2026), $693.2 million (Q4 2025), and $653.0 million (Q3 2025).

Peer Comparison